Zai Lab Announces Upcoming Presentations at January Investor Conferences

Rhea-AI Summary

Zai Lab Limited (NASDAQ: ZLAB) announced its participation in two virtual investor conferences in January 2022. The first is the 40th Annual J.P. Morgan Healthcare Conference on January 10, 2022, at 9:00 a.m. ET, followed by the BofA 2022 New York Asia Day on January 18, 2022, at 9:00 a.m. ET. A webcast link for the J.P. Morgan conference will be available on Zai Lab's website, with a replay accessible for 30 days. Zai Lab focuses on developing therapies for unmet medical needs in various fields, including oncology and autoimmune disorders.

SHANGHAI, SAN FRANCISCO and CAMBRIDGE, Mass., Dec. 29, 2021 (GLOBE NEWSWIRE) -- Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688), a patient-focused, innovative, commercial-stage, global biopharmaceutical company, today announced that management from Zai Lab will be presenting at the following virtual investor conferences in January:

40th Annual J.P. Morgan Healthcare Conference
Presentation: Monday, January 10, 2022, 9:00 a.m. ET

BofA 2022 New York Asia Day
Presentation: Tuesday, January 18, 2022, 9:00 a.m. ET

Webcast link of the 40th Annual J.P. Morgan Healthcare Conference will be available under “Events & Presentations” in the “Investor Relations” section of Zai Lab’s website. An archived replay will be available for 30 days following the event.

About Zai Lab

Zai Lab (NASDAQ: ZLAB; HKEX: 9688) is a patient-focused, innovative, commercial-stage, global biopharmaceutical company focused on developing and commercializing therapies that address medical conditions with unmet needs in oncology, autoimmune disorders, infectious diseases, and neuroscience. To that end, our experienced team has secured partnerships with leading global biopharmaceutical companies in order to generate a broad pipeline of innovative marketed products and product candidates. We have also built an in-house team with strong product discovery and translational research capabilities and are establishing a pipeline of proprietary product candidates with global rights. Our vision is to become a leading global biopharmaceutical company, discovering, developing, manufacturing and commercializing our portfolio in order to impact human health worldwide.

For additional information about the company, please visit www.zailaboratory.com or follow us at www.twitter.com/ZaiLab_Global.

For more information, please contact:

ZAI LAB CONTACTS:

Investor Relations: Ron Aldridge / Lina Zhang
+1 (781) 434-8465 / +86 136 8257 6943
ronald.aldridge@zailaboratory.com / lina.zhang@zailaboratory.com

Media: Danielle Halstrom / Xiaoyu Chen
+1 (215) 280-3898 / +86 185 0015 5011
danielle.halstrom@zailaboratory.com / xiaoyu.chen@zailaboratory.com 

Zai Lab Limited

Source: Zai Lab Limited

FAQ

When is Zai Lab's presentation at the 40th Annual J.P. Morgan Healthcare Conference?

Zai Lab will present at the 40th Annual J.P. Morgan Healthcare Conference on January 10, 2022, at 9:00 a.m. ET.

What date is Zai Lab presenting at the BofA 2022 New York Asia Day?

Zai Lab is scheduled to present at the BofA 2022 New York Asia Day on January 18, 2022, at 9:00 a.m. ET.

Where can I find the webcast for Zai Lab's J.P. Morgan Healthcare Conference presentation?

The webcast link for Zai Lab's presentation will be available under “Events & Presentations” in the Investor Relations section of Zai Lab's website.

How long will the replay of Zai Lab's J.P. Morgan presentation be available?

The archived replay of Zai Lab's presentation at the J.P. Morgan conference will be available for 30 days following the event.